PRAN Key Stats
- Why Given Imaging, Prana Biotechnology, and Alpha Natural Resources Are Today's 3 Best Stocks Fool Dec 9
- Notable 52-Week Highs and Lows of the Day 12/09: (MU) (PRAN) (GILD) High; (OSIS) (EW) (EZPW) Low Street Insider Dec 9
- Unusual 11 Mid-Day Movers 12/09: (HIHO) (GIVN) (PRAN) Higher; (OSIS) (GNE) (CRIS) Lower Street Insider Dec 9
- Prana Biotech (PRAN) Completes IMAGINE AD Trial Street Insider Dec 9
- Unusual 11 Mid-Day Movers 12/02: (BOSC) (VSCI) (DGLY) Higher; (ZOOM) (IR) (CIE) Lower Street Insider Dec 2
- 3 Drugmakers on the Move Fool Nov 22
- Prana's PBT2 Featured as a Top 10 Global Neuroscience Project Marketwired Nov 19
- Prana's PBT2 Features as a Top 10 Global Neuroscience Project Other Nov 18
- Prana Provides Update on IMAGINE Trial and Extension Trial for Alzheimer's Disease Marketwired Nov 18
- Prana Biotechnology (PRAN) Continues Higher Following Positive PBT2 Phase II Mention Street Insider Nov 15
PRAN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Prana Biotechnology is up 181.3% over the last year vs S&P 500 Total Return up 30.68%, Merrimack Pharmaceuticals down 27.90%, and Oxygen Biotherapeutics down 58.31%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Balance Sheet View Statement
Pro Ratings for PRAN
Pro Strategies Featuring PRAN
Did Prana Biotechnology make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Prana Biotechnology Limited is a development stage company at an early stage in the development of its pharmaceutical products. The Company’s activities include research into Alzheimer ’s disease and other major age-related degenerative disorders.